Krystal Biotech's VYJUVEK, a groundbreaking gene therapy for DEB, achieved $83.8M in Q3 2024 sales. Read why I rate KRYS ...

Douglas Elliman Inc. entered into a significant agreement regarding the assumption of an office lease. The company, based in Miami, Florida, signed the fourth amendment to the office lease agreement ...

Powell Industries plays a critical role in the AI value chain, focusing on electrical infrastructure solutions. Read why I ...

Yun Zhong, an analyst from Wedbush, has initiated a new Buy rating on Rocket Pharmaceuticals (RCKT).Don't Miss Our New Year's Offers:Discover ...

Shares of 4D Molecular Therapeutics, Inc. (NASDAQ:FDMT – Get Free Report) have earned a consensus rating of “Moderate Buy” from the eleven ratings firms that are currently covering the firm, ...

Noting AI and algorithmic trading are liquifying the municipal odd lot market (an odd lot is a block of bonds trading at $100 ...

We recently compiled a list of the 10 Best Gene Therapy Stocks to Buy Right Now. In this article, we are going to take a look ...

We recently published a list of Top 12 Luxury Stocks According to Hedge Funds. In this article, we are going to take a look ...

DFA International Vector Equity Port earns an Above Average ... Examining additional factor exposure, this strategy continually held some stocks with low trading volume over the last few years.

BigBear.ai has captured investor attention with incredible gains in 2024. Is it a smart buy for the coming year, though?